slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,54 CNY | +3,66% | +12,49% | -21,36% |
Vakgebied
Aantal werknemers: 1 961
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug
98,4
%
| 2 342 | 98,6 % | 2 417 | 98,4 % | +3,17% |
Promotional Services
0,9
%
| 19 | 0,8 % | 22 | 0,9 % | +15,37% |
Factory Rental
0,7
%
| 14 | 0,6 % | 16 | 0,7 % | +11,48% |
Others
0,0
%
| 0 | 0,0 % | 1 | 0,0 % | +126,44% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 2 376 | 100,0 % | 2 455 | 100,0 % | +3,32% |
Abroad
0,0
%
| 0 | 0,0 % | 1 | 0,0 % | +126,04% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jia Tong
CEO | Chief Executive Officer | 46 | 01-01-03 |
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07-01-03 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 01-01-16 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01-04-11 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 28-02-16 |
Jian Hao Shen
IRC | Investor Relations Contact | - | - |
Ling Xi Wu
SEC | Corporate Secretary | 41 | 24-09-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07-01-03 |
Wei Wang
BRD | Director/Board Member | 57 | 22-11-19 |
Jiang Nan Cai
BRD | Director/Board Member | 67 | 22-11-19 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 28-02-16 |
Zhi Hua Yu
BRD | Director/Board Member | 56 | 06-09-17 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01-04-11 |
Yang Nan Zhang
CHM | Chairman | 52 | 22-11-18 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 01-01-16 |
Tian Xu
BRD | Director/Board Member | 62 | 17-10-22 |
Xin Qi Huang
BRD | Director/Board Member | 53 | 22-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 418 485 885 | 215 716 338 ( 51,55 %) | 0 | 51,55 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
C4 THERAPEUTICS, INC. 8.12% | 5 567 928 | 8.12% | 45 489 972 $ |
Bedrijfsgegevens
Betta Pharmaceuticals Co., Ltd.
355 Xingzhong Road Yuhang Economic & Tech Dev Zone
311100, Hangzhou
+
http://www.bettapharma.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,36% | 2,34 mld. | |
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-29,67% | 2,2 mld. | |
+8,38% | 1,96 mld. | |
+3,90% | 1,65 mld. |
- Beurs
- Aandelen
- Koers 300558
- Onderneming Betta Pharmaceuticals Co., Ltd.